Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
NOV
(NYSE:NOV)
Intraday
$18.845
-0.105
[-0.55%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$18.845
-0.105
[-0.55%]
Last update: 11:32AM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings were released on Thu Apr 25th, after the market close
Today's conference call ended over 4 hours ago
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for NOV Stock (NYSE:NOV)
NOV Stock (NYSE: NOV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
NOV Q1 EPS $0.30 Beats $0.27 Estimate, Sales $2.15B Beat $2.11B Estimate
Benzinga Newsdesk
-
17 hours ago
Monday, April 08, 2024
Expert Ratings For NOV
Benzinga Insights
-
Apr 8, 2024, 12:00PM
Susquehanna Maintains Positive on NOV, Maintains $26 Price Target
Benzinga Newsdesk
-
Apr 8, 2024, 11:27AM
Monday, March 11, 2024
Arcosa Illuminates Its Portfolio with $180M Ameron Pole Products Acquisition
Shivani Kumaresan
-
Mar 11, 2024, 10:48AM
Arcosa Announces Agreement To Acquire Ameron Pole Products From NOV Inc. For $180M In Cash
Benzinga Newsdesk
-
Mar 11, 2024, 8:09AM
Tuesday, February 20, 2024
Piper Sandler Maintains Neutral Rating for NOV: Here's What You Need To Know
Benzinga Insights
-
Feb 20, 2024, 12:00PM
Tuesday, February 06, 2024
In-Depth Examination Of 5 Analyst Recommendations For NOV
Benzinga Insights
-
Feb 6, 2024, 11:00AM
RBC Capital Reiterates Sector Perform on NOV, Maintains $24 Price Target
Benzinga Newsdesk
-
Feb 6, 2024, 10:58AM
Monday, February 05, 2024
Stifel Maintains Buy on NOV, Lowers Price Target to $26-Report Released on 4 February 2024
Benzinga Newsdesk
-
Feb 5, 2024, 4:13PM
Raymond James Maintains Outperform on NOV, Lowers Price Target to $25
Benzinga Newsdesk
-
Feb 5, 2024, 7:34AM
Thursday, February 01, 2024
NOV Q4 EPS $1.51 Beats $0.41 Estimate, Sales $2.34B Beat $2.26B Estimate
Benzinga Newsdesk
-
Feb 1, 2024, 5:38PM
Earnings Scheduled For February 1, 2024
Benzinga Insights
-
Feb 1, 2024, 5:03AM
Wednesday, January 31, 2024
Earnings Outlook For NOV
Benzinga Insights
-
Jan 31, 2024, 10:01AM
Tuesday, January 30, 2024
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 30, 2024, 1:18PM
Tuesday, January 16, 2024
Benchmark Downgrades NOV to Hold
Benzinga Newsdesk
-
Jan 16, 2024, 3:07PM
Thursday, December 14, 2023
Shares of oil companies are trading higher amid a rise in oil following Wednesday's Fed decision. Potential rate cuts in the future could help lift oil demand growth.
Benzinga Newsdesk
-
Dec 14, 2023, 12:47PM
Tuesday, December 12, 2023
TD Cowen Maintains Outperform on NOV, Raises Price Target to $29
Benzinga Newsdesk
-
Dec 12, 2023, 7:55AM
Friday, December 08, 2023
The Latest Analyst Ratings for NOV
Benzinga Insights
-
Dec 8, 2023, 7:00AM
JP Morgan Upgrades NOV to Overweight, Announces $25 Price Target
Benzinga Newsdesk
-
Dec 8, 2023, 6:40AM
Monday, December 04, 2023
Ascent Industries Appoints John W. "Wes" Johnson As President Of Ascent Tubular, Effective December 4, 2023
Benzinga Newsdesk
-
Dec 4, 2023, 8:45AM
Thursday, November 16, 2023
Shares of energy stocks are trading lower following a build in crude and natural gas inventories.
Benzinga Newsdesk
-
Nov 16, 2023, 1:05PM
Monday, October 30, 2023
RBC Capital Maintains Sector Perform on NOV, Raises Price Target to $24
Benzinga Newsdesk
-
Oct 30, 2023, 2:29PM
Raymond James Maintains Outperform Rating for NOV: Here's What You Need To Know
Benzinga Insights
-
Oct 30, 2023, 1:00PM
Raymond James Maintains Outperform on NOV, Raises Price Target to $29
Benzinga Newsdesk
-
Oct 30, 2023, 8:05AM
Thursday, October 26, 2023
NOV Q3 2023 EPS $0.29 Up From $0.08 YoY, Revenue $2.19B Beats $2.127B Estimate
Benzinga Newsdesk
-
Oct 26, 2023, 5:03PM
Earnings Scheduled For October 26, 2023
Benzinga Insights
-
Oct 26, 2023, 7:20AM
Wednesday, October 25, 2023
NOV Earnings Preview
Benzinga Insights
-
Oct 25, 2023, 1:00PM
Tuesday, October 17, 2023
Morgan Stanley Maintains Overweight on NOV, Raises Price Target to $25
Benzinga Newsdesk
-
Oct 17, 2023, 10:29AM
Monday, October 09, 2023
Shares of energy stocks are trading higher as the Israel-Hamas conflict drives oil supply uncertainty.
Benzinga Newsdesk
-
Oct 9, 2023, 11:52AM
Wednesday, October 04, 2023
Shares of energy stocks are trading lower amid a drop in oil prices.
Benzinga Newsdesk
-
Oct 4, 2023, 3:39PM
Tuesday, October 03, 2023
Analyst Expectations for NOV's Future
Benzinga Insights
-
Oct 3, 2023, 4:01PM
Wells Fargo Maintains Equal-Weight on NOV, Raises Price Target to $21
Benzinga Newsdesk
-
Oct 3, 2023, 8:38AM
Wednesday, August 09, 2023
Goldman Sachs Maintains Sell on NOV, Raises Price Target to $18
Benzinga Newsdesk
-
Aug 9, 2023, 11:52AM
Thursday, August 03, 2023
Top 5 Energy Stocks That Should Keep You Up At Night
Lisa Levin
-
Aug 3, 2023, 8:26AM
Tuesday, August 01, 2023
Citigroup Maintains Buy on NOV, Raises Price Target to $26
Benzinga Newsdesk
-
Aug 1, 2023, 10:14AM
Monday, July 31, 2023
Piper Sandler Maintains Neutral on NOV, Lowers Price Target to $20
Benzinga Newsdesk
-
Jul 31, 2023, 12:40PM
Analyst Expectations for NOV's Future
Benzinga Insights
-
Jul 31, 2023, 10:00AM
Morgan Stanley Maintains Overweight on NOV, Raises Price Target to $24
Benzinga Newsdesk
-
Jul 31, 2023, 9:51AM
Benchmark Reiterates Buy on NOV, Maintains $28 Price Target
Benzinga Newsdesk
-
Jul 31, 2023, 8:45AM
Citigroup Maintains Buy on NOV, Raises Price Target to $26
Benzinga Newsdesk
-
Jul 31, 2023, 7:22AM
Raymond James Maintains Outperform on NOV, Raises Price Target to $28
Benzinga Newsdesk
-
Jul 31, 2023, 4:39AM
Friday, July 28, 2023
Wells Fargo Maintains Equal-Weight on NOV, Raises Price Target to $20
Benzinga Newsdesk
-
Jul 28, 2023, 11:47AM
Wednesday, July 26, 2023
NOV Q2 EPS $0.39 Beats $0.30 Estimate, Sales $2.09B Beat $2.08B Estimate
Bill Haddad
-
Jul 26, 2023, 5:06PM
Earnings Scheduled For July 26, 2023
Benzinga Insights
-
Jul 26, 2023, 4:18AM
Tuesday, July 18, 2023
Citigroup Maintains Buy on NOV, Lowers Price Target to $21
Benzinga Newsdesk
-
Jul 18, 2023, 12:07PM
What The Nasdaq-100 Will Look Like After July 24
GRIT Capital
-
Jul 18, 2023, 10:50AM
Monday, July 17, 2023
Morgan Stanley Reiterates Overweight on NOV, Maintains $22 Price Target
Benzinga Newsdesk
-
Jul 17, 2023, 10:16AM
Friday, July 14, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Benzinga Insights
-
Jul 14, 2023, 11:02AM
The Latest Analyst Ratings for NOV
Benzinga Insights
-
Jul 14, 2023, 11:00AM
Capital One Initiates Coverage On NOV with Equal-Weight Rating, Announces Price Target of $20
Benzinga Newsdesk
-
Jul 14, 2023, 10:32AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch